NO20012367L - Behandling av tumorer ved administrering av veksthormonfrigjörende forbindelser og deres antagonister - Google Patents

Behandling av tumorer ved administrering av veksthormonfrigjörende forbindelser og deres antagonister

Info

Publication number
NO20012367L
NO20012367L NO20012367A NO20012367A NO20012367L NO 20012367 L NO20012367 L NO 20012367L NO 20012367 A NO20012367 A NO 20012367A NO 20012367 A NO20012367 A NO 20012367A NO 20012367 L NO20012367 L NO 20012367L
Authority
NO
Norway
Prior art keywords
antagonists
tumors
administration
treatment
growth hormone
Prior art date
Application number
NO20012367A
Other languages
English (en)
Norwegian (no)
Other versions
NO20012367D0 (no
Inventor
Giampiero Muccioli
Mauro Papotti
Ezio Ghigo
Romano Deghenghi
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO20012367D0 publication Critical patent/NO20012367D0/no
Publication of NO20012367L publication Critical patent/NO20012367L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO20012367A 1998-11-16 2001-05-14 Behandling av tumorer ved administrering av veksthormonfrigjörende forbindelser og deres antagonister NO20012367L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/192,406 US6124263A (en) 1998-11-16 1998-11-16 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
PCT/EP1999/008662 WO2000029011A1 (en) 1998-11-16 1999-11-11 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists

Publications (2)

Publication Number Publication Date
NO20012367D0 NO20012367D0 (no) 2001-05-14
NO20012367L true NO20012367L (no) 2001-07-09

Family

ID=22709509

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012367A NO20012367L (no) 1998-11-16 2001-05-14 Behandling av tumorer ved administrering av veksthormonfrigjörende forbindelser og deres antagonister

Country Status (30)

Country Link
US (1) US6124263A (hu)
EP (1) EP1131083B1 (hu)
JP (1) JP2002529512A (hu)
KR (1) KR100704138B1 (hu)
CN (3) CN100368014C (hu)
AR (1) AR021286A1 (hu)
AT (1) ATE258062T1 (hu)
BG (1) BG105572A (hu)
BR (1) BR9915390A (hu)
CA (1) CA2350914A1 (hu)
CO (1) CO5140111A1 (hu)
CZ (1) CZ20011577A3 (hu)
DE (1) DE69914365T2 (hu)
DK (1) DK1131083T3 (hu)
ES (1) ES2212650T3 (hu)
HK (1) HK1040934A1 (hu)
HU (1) HUP0104374A3 (hu)
IL (1) IL142858A0 (hu)
MX (1) MXPA01004689A (hu)
NO (1) NO20012367L (hu)
NZ (1) NZ511280A (hu)
PL (1) PL347659A1 (hu)
PT (1) PT1131083E (hu)
RU (1) RU2240133C2 (hu)
SK (1) SK6352001A3 (hu)
TR (1) TR200101350T2 (hu)
TW (2) TWI237565B (hu)
UA (1) UA73100C2 (hu)
WO (1) WO2000029011A1 (hu)
ZA (1) ZA200103182B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6211156B1 (en) * 1999-11-10 2001-04-03 Asta Medica A.G. Peptides for treatment of erectile dysfunction
CU23157A1 (es) * 2001-01-03 2006-07-18 Ct Ingenieria Genetica Biotech COMPOSICION FARMACéUTICA PARA EL TRATAMIENTO DEL DANO TISULAR DEBIDO A FALTA DE IRRIGACION SANGUINEA ARTERIAL
DE10112882A1 (de) * 2001-03-15 2002-09-19 Max Delbrueck Centrum Verwendung von Tryptophan-Derivaten zur spezifischen zytostatischen Behandlung von Serotonin-produzierenden Tumoren
EP1385879A4 (en) * 2001-05-10 2005-02-02 Univ Queensland DIAGNOSIS AND THERAPY OF CANCER OF REPRODUCTIVE ORGANS
EP1312363A1 (en) * 2001-09-28 2003-05-21 Pfizer Products Inc. Methods of treatment and kits comprising a growth hormone secretagogue
TWI331922B (en) * 2002-08-09 2010-10-21 Ipsen Pharma Sas Growth hormone releasing peptides
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US20050164952A1 (en) * 2004-01-23 2005-07-28 Vital Pharmaceuticals, Inc. Delivery system for growth hormone releasing peptides
US8536120B2 (en) * 2006-04-28 2013-09-17 The Administrators Of The Tulane Educational Fund Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
US8299022B2 (en) 2006-09-27 2012-10-30 Ipsen Pharma S.A.S. Analogs of ghrelin substituted at the N-terminal
WO2008100448A2 (en) 2007-02-13 2008-08-21 Helsinn Therapeutics (U.S.), Inc. Method of treating cell proliferative disorders using growth hormone secretagogues
US8841257B2 (en) * 2009-04-10 2014-09-23 Board Of Regents, The University Of Texas System Inhibitors of STAT3 and uses thereof
US9724381B2 (en) 2009-05-12 2017-08-08 The Administrators Of The Tulane Educational Fund Methods of inhibiting the ghrelin/growth hormone secretatogue receptor pathway and uses thereof
IT1399610B1 (it) * 2010-01-28 2013-04-26 Univ Milano Bicocca Uso di agonisti e antagonisti dei recettori per i growth hormone secretagogues per la prevenzione e il trattamento di convulsioni ed epilessia
AU2020218272A1 (en) 2019-02-08 2021-09-02 United States Government As Represented By The Department Of Veterans Affairs Growth hormone-releasing hormone antagonists and uses thereof
CA3143758A1 (en) * 2019-07-18 2021-01-21 University Of Miami Ghrh antagonists for use in a method of treating sarcoidosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2053250A1 (en) * 1989-04-26 1990-10-27 David H. Coy Linear somatostatin analogs
IT1240643B (it) * 1990-05-11 1993-12-17 Mediolanum Farmaceutici Spa Peptidi biologicamente attivi contenenti in catena 2-alchiltriptofano
US5385682A (en) * 1990-05-15 1995-01-31 Exxon Research & Engineering Co. Grease composition
ATE284413T1 (de) * 1993-08-09 2004-12-15 Sod Conseils Rech Applic Therapeutische peptid derivate
US5550212A (en) * 1993-12-17 1996-08-27 The Administrators Of The Tulane Educational Fund Analogues of hGH-RH(1-29)NH2 having antagonistic activity
US5807985A (en) * 1996-06-11 1998-09-15 Deghenghi; Romano Oligopeptide compounds containing D-2-alkyltryptophan capable of promoting the release of growth hormone
US6063796A (en) * 1997-04-04 2000-05-16 Merck & Co., Inc. Somatostatin agonists

Also Published As

Publication number Publication date
PT1131083E (pt) 2004-06-30
HUP0104374A2 (hu) 2002-04-29
TWI237565B (en) 2005-08-11
PL347659A1 (en) 2002-04-22
JP2002529512A (ja) 2002-09-10
TWI263642B (en) 2006-10-11
DK1131083T3 (da) 2004-04-26
RU2240133C2 (ru) 2004-11-20
DE69914365T2 (de) 2004-11-04
EP1131083A1 (en) 2001-09-12
TW200530270A (en) 2005-09-16
CZ20011577A3 (cs) 2002-07-17
ES2212650T3 (es) 2004-07-16
NZ511280A (en) 2002-10-25
CN1277840C (zh) 2006-10-04
KR20010089459A (ko) 2001-10-06
NO20012367D0 (no) 2001-05-14
EP1131083B1 (en) 2004-01-21
CN1326353A (zh) 2001-12-12
UA73100C2 (en) 2005-06-15
IL142858A0 (en) 2002-03-10
HUP0104374A3 (en) 2003-03-28
ZA200103182B (en) 2001-09-07
CO5140111A1 (es) 2002-03-22
US6124263A (en) 2000-09-26
ATE258062T1 (de) 2004-02-15
WO2000029011A1 (en) 2000-05-25
DE69914365D1 (de) 2004-02-26
AR021286A1 (es) 2002-07-03
BR9915390A (pt) 2001-08-07
SK6352001A3 (en) 2002-09-10
KR100704138B1 (ko) 2007-04-09
CN1895660A (zh) 2007-01-17
BG105572A (en) 2002-01-31
TR200101350T2 (tr) 2001-11-21
CN1200726C (zh) 2005-05-11
HK1040934A1 (zh) 2002-06-28
CA2350914A1 (en) 2000-05-25
MXPA01004689A (es) 2002-09-18
CN100368014C (zh) 2008-02-13
CN1594358A (zh) 2005-03-16

Similar Documents

Publication Publication Date Title
NO20012367D0 (no) Behandling av tumorer ved administrering av veksthormonfrigjörende forbindelser og deres antagonister
NO20002721D0 (no) Heterocykliske forbindelser for inhibitering av gastrisk syresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
DE60024988D1 (de) Herstellung von therapeutischem mikroschaum
DE69942928D1 (de) Therapeutische formulierung zur verabreichung von tolterodin mit kontrollierter freisetzung
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
NO20040936L (no) Plaster for behandling av dysfunksjoner og forstyrrelser ved neglevekst.
EE200200118A (et) Terapeutilised kinasoliini derivaadid, nende valmistamise meetod ning kasutamine
EE200100717A (et) Indasooliühendid ja farmatseutilised kompositsioonid proteiini kinaaside inhibeerimiseks ja meetodid nende kasutamiseks
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
NO986089L (no) Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer og kakeksi
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
EE04717B1 (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
NO931186L (no) Terapeutisk aktive imidazolderivater, fremgangsmaate for deres fremstilling og anvendelse derav
NO20003229D0 (no) Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske legemidler for behandling av proliferaktive sykdommer
IL156139A0 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
NO20014049D0 (no) Kontrollert frigjorings-formulering for behandling av COPD
DE69916488D1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
NO20014848L (no) Fremgangsmåte for anvendelse av emamectin for behandling av fiskeparasitter
EE200000193A (et) Kasvuhormoonide sekreteerimist stimuleerivate ühendite valmistamise protsess
EP1173189A4 (en) ASIALOZYTOKINES AND TREATMENT OF LIVER DISEASES
NO20022990D0 (no) Fremgangsmåte og sammensetning for behandling av smerte
ATE261965T1 (de) Bispidin-derivate zur behandlung von herzarrhythmien
HUP0301971A3 (en) Uses of thaliporphine or its derivatives for producing pharmaceutical compositions suitable for treating cardiac diseases and the compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application